Gastrointestinal bleeding (GIB) presents a diagnostic and therapeutic challenge to healthcare professionals. As an acute medical emergency, it requires a systematic approach for accurate diagnosis and effective management.
The first step in the clinical approach to GIB is identifying the source of the bleed, which can be broadly categorized into upper and lower GIB. Upper GIB, originating proximal to the ligament of Treitz, often presents with hematemesis or melena. Lower GIB, distal to the ligament, frequently results in hematochezia. However, these presentations can overlap, adding to the complexity of diagnosis.
Initial evaluation should include a thorough history, physical examination, and laboratory testing. Hemodynamic stability should be assessed and resuscitation initiated if necessary. Early risk stratification, using tools such as the Glasgow-Blatchford score, can guide management decisions and triage patients appropriately.
Endoscopic evaluation remains the cornerstone of diagnosis. Upper endoscopy and colonoscopy can identify the source of the bleed in most cases. If these are non-diagnostic, capsule endoscopy or angiography may be employed. In cases of obscure GIB, enteroscopy or radionuclide scanning may be considered.
Treatment of GIB depends on the source and severity of the bleed. Endoscopic therapy, including injection, coagulation, and mechanical therapies, is effective for most causes of GIB. In refractory cases, angiographic embolization or surgery may be necessary.
Managing GIB requires a comprehensive, systematic approach. Early identification, appropriate risk stratification, and timely intervention are key to improving patient outcomes. As our understanding of GIB continues to evolve, so too will our clinical approach, promising improved diagnostic and therapeutic strategies in the future.
1.
AI-based liquid biopsy shows promise for detecting brain cancer
2.
To refute accusations that it failed to issue a cancer warning, Roundup's maker is asking lawmakers for assistance.
3.
Aspirin Fails to Boost Survival in Colorectal Cancer Trial
4.
Ignoring Colonoscopy Advice; Dry Mouth Acupuncture; Inflamed Tongue, Then Cancer.
5.
Males with early-onset colorectal cancer are at risk, according to a study.
1.
Advances in Cancer Detection: From Genetic Risk to Molecular Biomarkers
2.
Metabolic Reprogramming of the Tumor Microenvironment: Mechanisms, Clinical Relevance, and Emerging Therapeutic Strategies
3.
Multidisciplinary Insights into Diagnosis, Management, and Outcomes in Oncology
4.
Innovative Breakthroughs in Hematology for Modern Medicine
5.
Precision Erythropoietic Modeling for Hematologic Disorders
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Role of Screening in Cancer Prevention
2.
Innovations in Hematology
3.
Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2
4.
A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation